Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs Metoprolol in Hypertension with Amlodipine Background
NCT03635125Phase 4Completed
- Sponsor
- Trinity Hypertension & Metabolic Research Institute
- Start
- Aug 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nebivolol in hypertension (HTN) (2 arms), sponsored by Trinity Hypertension & Metabolic Research Institute. Primary endpoints: Mean Change from baseline in trough Diastolic Blood Pressure at 8 weeks and Mean Change in Edema Measurement at 8 weeks. Started Aug 2010; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03635125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03635125.